Multivariate analysis of the predictive ability of different variables (presence of MetS, number of MetS criteria or circulating CRP levels) to predict a higher risk of Sig‐PCa adjusting by age, PSA, 5‐α reductase inhibitors intake, DRE, prostate volume and number of biopsies. This evidence concerns the gene CRP and posterior cortical atrophy.